Literature DB >> 30670468

Chaperoning Endoplasmic Reticulum-Associated Degradation (ERAD) and Protein Conformational Diseases.

Patrick G Needham1, Christopher J Guerriero1, Jeffrey L Brodsky1.   

Abstract

Misfolded proteins compromise cellular homeostasis. This is especially problematic in the endoplasmic reticulum (ER), which is a high-capacity protein-folding compartment and whose function requires stringent protein quality-control systems. Multiprotein complexes in the ER are able to identify, remove, ubiquitinate, and deliver misfolded proteins to the 26S proteasome for degradation in the cytosol, and these events are collectively termed ER-associated degradation, or ERAD. Several steps in the ERAD pathway are facilitated by molecular chaperone networks, and the importance of ERAD is highlighted by the fact that this pathway is linked to numerous protein conformational diseases. In this review, we discuss the factors that constitute the ERAD machinery and detail how each step in the pathway occurs. We then highlight the underlying pathophysiology of protein conformational diseases associated with ERAD.
Copyright © 2019 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Year:  2019        PMID: 30670468      PMCID: PMC6671943          DOI: 10.1101/cshperspect.a033928

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  39 in total

1.  A technique for delineating the unfolding requirements for substrate entry into retrotranslocons during endoplasmic reticulum-associated degradation.

Authors:  Junfen Shi; Xianyan Hu; Yuan Guo; Linhan Wang; Jia Ji; Jiqiang Li; Zai-Rong Zhang
Journal:  J Biol Chem       Date:  2019-11-20       Impact factor: 5.157

2.  Maintenance of Endoplasmic Reticulum Protein Homeostasis in Cancer: Friend or Foe.

Authors:  Mari McMahon; Afshin Samali; Eric Chevet
Journal:  Prog Mol Subcell Biol       Date:  2021

3.  Ubiquitination of disease-causing CFTR variants in a microsome-based assay.

Authors:  Samuel K Estabrooks; Jeffrey L Brodsky
Journal:  Anal Biochem       Date:  2020-07-01       Impact factor: 3.365

4.  The Capture of a Disabled Proteasome Identifies Erg25 as a Substrate for Endoplasmic Reticulum Associated Degradation.

Authors:  Teresa M Buck; Xuemei Zeng; Pamela S Cantrell; Richard T Cattley; Zikri Hasanbasri; Megan E Yates; Diep Nguyen; Nathan A Yates; Jeffrey L Brodsky
Journal:  Mol Cell Proteomics       Date:  2020-08-31       Impact factor: 5.911

5.  The cytoplasmic tail of human mannosidase Man1b1 contributes to catalysis-independent quality control of misfolded alpha1-antitrypsin.

Authors:  Ashlee H Sun; John R Collette; Richard N Sifers
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-21       Impact factor: 11.205

6.  Induction via Functional Protein Stabilization of Hepatic Cytochromes P450 upon gp78/Autocrine Motility Factor Receptor (AMFR) Ubiquitin E3-Ligase Genetic Ablation in Mice: Therapeutic and Toxicological Relevance.

Authors:  Doyoung Kwon; Sung-Mi Kim; Peyton Jacob; Yi Liu; Maria Almira Correia
Journal:  Mol Pharmacol       Date:  2019-09-06       Impact factor: 4.436

7.  The Degron Architecture of Squalene Monooxygenase and How Specific Lipids Calibrate Levels of This Key Cholesterol Synthesis Enzyme.

Authors:  Ngee Kiat Chua; Andrew J Brown
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  Disposing of misfolded ER proteins: A troubled substrate's way out of the ER.

Authors:  Christina Oikonomou; Linda M Hendershot
Journal:  Mol Cell Endocrinol       Date:  2019-10-24       Impact factor: 4.102

Review 9.  Cell-Nonautonomous Regulation of Proteostasis in Aging and Disease.

Authors:  Richard I Morimoto
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-04-01       Impact factor: 10.005

Review 10.  The Proteasome and Its Network: Engineering for Adaptability.

Authors:  Daniel Finley; Miguel A Prado
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-01-02       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.